The reclassification of cannabis as a Schedule III substance is meant to remove barriers for researchers but its effects ...

The move will bring enormous tax benefits to medical marijuana producers and may speed research into its effects, experts say ...

Over the last three decades, 40 states have legalized the sale and use of medical marijuana in one form or another. Last week, the federal government followed suit, and the policy change could have ...

The federal government is reclassifying medical marijuana, categorizing it as a drug with potential medical benefits and less ...

When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set ...

On April 22, Bloomberg reported, citing an on-air discussion with CEO Irwin Simon, that Tilray Brands, Inc. (NASDAQ:TLRY) ...

Companies developing cannabis-based medicines say U. moves to loosen restrictions on the drug could unlock private funding ...

The federal government reclassified marijuana from Schedule I to Schedule III, impacting Oklahoma's medical marijuana ...

The U.S. Department of Justice (DOJ) has reclassified certain marijuana and marijuana-containing products to Schedule III ...

Acting Attorney General Todd Blanche signed an order under President Trump’s direction on Thursday to reclassify ...